USB1 is a miRNA deadenylase that regulates hematopoietic development

Area of Science:

• Molecular Biology
• Hematology
• Genetics

Background:

• Mutations in the 3' to 5' RNA exonuclease USB1 are linked to poikiloderma with neutropenia (PN), a condition causing hematopoietic failure.
• The precise molecular mechanism of PN, despite USB1's known role in U6 small nuclear RNA maturation, remains unclear as pre-mRNA splicing is unaffected.

Purpose of the Study:

• To investigate the role of USB1 mutations in human hematopoiesis.
• To elucidate the molecular pathways contributing to hematopoietic failure in PN.
• To identify potential therapeutic targets for PN.

Main Methods:

• Generated human embryonic stem cells with a PN-associated mutation (c.531_delA) in USB1.
• Analyzed microRNA (miRNA) levels and 3'-end adenylation in USB1 mutant cells.
• Assessed the impact of inhibiting PAPD5/7 on hematopoiesis in USB1 mutants.

Main Results:

• The c.531_delA mutation in USB1 impairs human hematopoiesis.
• Dysregulated miRNA levels, due to a failure to remove 3'-end adenylated tails added by PAPD5/7, contribute to hematopoietic failure in USB1 mutants.
• Inhibition of PAPD5/7 rescues hematopoiesis in USB1 mutants.

Conclusions:

• USB1 functions as a crucial miRNA deadenylase.
• The study identifies PAPD5/7 as key players in USB1-associated hematopoietic failure.
• Inhibition of PAPD5/7 presents a potential therapeutic strategy for poikiloderma with neutropenia.